BUY GlaxoSmithKline Pharmaceuticals Limited — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Swing (≤2wk))28 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nestle, GSK Pharma Show Momentum as Market Faces Pressure
NewsGoogle News·23 Jul · 5d ago
Nestle, GSK Pharma में तेजी के संकेत, गिरावट में बाजार
NewsGoogle News·23 Jul · 5d ago
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·23 Jul · 5d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on GlaxoSmithKline Pharmaceuticals
- BUY — IDBI Capital23 Sept 2026 · ~2 weeks · target ₹3,062 · SL hit
- BUY — Kunal Bothra27 Aug 2026 · ~2 weeks · target ₹3,200 · SL hit
- BUY — Rakesh Bansal19 Aug 2026 · ~3 months · target ₹3,700 · Active
- BUY — Akshay Bhagwat, JM Financial18 Aug 2026 · ~2 weeks · target ₹2,975 · Target hit
- BUY — Kush Bohra23 Jul 2026 · ~2 weeks · target ₹2,725 · SL hit
More from Prakash Gaba
- BUY Orient Cement22 Oct 2026 · ~2 weeks · target ₹120 · SL hit
- SELL Coforge22 Oct 2026 · ~2 weeks · target ₹1,870 · Active
- BUY EIH22 Oct 2026 · Same day · target ₹305 · SL hit
- BUY The Indian Hotels Company22 Oct 2026 · Same day · target ₹780 · Target hit
- BUY Anand Rathi Wealth22 Oct 2026 · Same day · target ₹2,240 · Target hit

